BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
All that You Really want to Be aware of Dental Inserts Facilities - 2The Drone Video of the Year is stunning – you've not seen Namibia like this
- 3Vial marked 'Polonium 210' sparks scare during German Easter egg hunt
- 4They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 5Top notch Remote Earphones for Audiophiles
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Germany's Deutsche Welle broadcaster declared 'undesirable' in Russia
- Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- 'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
- Why doing good also makes us feel good, during the holidays and beyond
- Von der Leyen: Paris meeting sends signal of unity for Ukraine
- Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.
- Somaliland denies trading recognition with Israel for accepting Gazans
- Agricultural drones are taking off globally, saving farmers time and money
